Results 81 to 90 of about 277 (133)
Plaque radiotherapy in the management of retinoblastoma
Retinoblastoma is the most common intraocular malignant tumor in childhood and is radiosensitive. We treated five patients with solitary intraocular retinoblastoma using iodine-125 plaque radiotherapy as a primary procedure.
H Kiratli, S Bilgiç, I L Atahan
doaj
Monte Carlo Dosimetry for 125I Eye Plaque Brachytherapy
Mahdi Sadeghi +4 more
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Episcleral plaque brachytherapy for retinoblastoma
Pediatric Blood & Cancer, 2004AbstractBackgroundThe purpose of this study was to report our experience using episcleral plaque brachytherapy (EPBRT) to treat retinoblastoma and to demonstrate its applicability in multimodality treatment.ProcedureWe treated 26 tumors in 25 eyes from a group of 21 children with unilateral (n = 4) or bilateral (n = 17) retinoblastoma.
Thomas E, Merchant +5 more
openaire +2 more sources
Seed localization in eye plaque brachytherapy
Medical Physics, 1998We describe a simple method for localizing seeds in eye plaques used for brachytherapy treatment of intraocular tumors and age‐related macular degeneration. The method is based on obtaining magnified photocopy images of plaques with seeds in place and then using simple geometrical considerations to reconstruct seed coordinates with about 2% accuracy. A
R S, Emery, A, Szechter
openaire +2 more sources
Ruthenium-106 plaque brachytherapy for uveal melanoma
British Journal of Ophthalmology, 2015To report on local tumour control, eye preservation and visual outcome after ruthenium-106 brachytherapy for uveal melanoma.Medical records of 143 eyes with uveal melanoma, treated by ruthenium-106 brachytherapy between 1997 and 2012 at one single centre, were included.
Lisa, Tarmann +6 more
openaire +2 more sources
The Impacts of Episcleral Plaque Brachytherapy on Ocular Motility
Journal of Binocular Vision and Ocular Motility, 2021Background: To investigate the effect of various factors on ocular motility disturbance after episcleral plaque brachytherapy with Ruthenium 106 (106Ru).Methods: Twenty consecutive patients who underwent plaque brachytherapy for all types of intraocular tumors were included in this interventional prospective case series.
Kaveh Abri Aghdam +5 more
openaire +2 more sources
2017
Episcleral plaque brachytherapy for appropriately selected patients (medium-sized tumors with an apical height of 2.5–10 mm and maximum basal diameter of
Tijana Skrepnik +3 more
openaire +1 more source
Episcleral plaque brachytherapy for appropriately selected patients (medium-sized tumors with an apical height of 2.5–10 mm and maximum basal diameter of
Tijana Skrepnik +3 more
openaire +1 more source
β-Ray brachytherapy with 106Ru plaques for retinoblastoma
International Journal of Radiation Oncology*Biology*Physics, 2006A retrospective analysis of 134 patients who received (106)Ru brachytherapy for retinoblastomas (175 tumors in 140 eyes). Treatment and follow-up were analyzed with special emphasis on tumor control organ, preservation, and late complications.Treated tumors had a mean height and diameter of 3.7+/-1.4 mm and 5.0+/-2.8 disk diameters, respectively.
Andreas O, Schueler +7 more
openaire +2 more sources
Custom-made “nag” eye plaques for 125i brachytherapy
International Journal of Radiation Oncology*Biology*Physics, 2003To report our experience in treating medium-size ocular melanomas with custom-made "Nag" eye plaques.Seventy-eight patients with medium-size ocular melanomas were treated with plaques of 0.6-mm-thick, 18k gold with a radius of curvature of 12 mm to conform to the curvature of the eyeball.
Subir, Nag +5 more
openaire +2 more sources
Episcleral Plaque Brachytherapy
Seminars in OphthalmologyEpiscleral plaque brachytherapy is a treatment method for ocular tumors that involves placing radionuclide sources directly on or around the tumor using an episcleral plaque. This technique offers the advantage of a highly focused radiation dose, minimizing exposure to critical eye structures. Various radionuclides such as I-125, Ru-106, and Pd-103 are
Vishal, Raval +2 more
openaire +2 more sources

